- Labcorp (NYSE:LH) on Friday said the listing of its planned spinoff of its clinical development business Fortrea had been approved by the Nasdaq stock market.
- The company is pursuing the spinoff as a tax-free transaction through a dividend of Fortrea's shares to the company's shareholders.
- LH in Friday's statement also announced a record date of 1700 Burlington, North Carolina time on June 20 and a distribution date of 2359 Burlington, North Carolina time on June 30 for the spinoff.
- Fortrea's common stock will be listed on the Nasdaq stock market under the symbol "FTRE."
More on Labcorp's spinoff
Recommended For You
More Trending News
See More »